Evaluation of the QT interval in patients with drug-induced QT prolongation and torsades de pointes

J Cardiovasc Electrophysiol. 2020 Oct;31(10):2696-2701. doi: 10.1111/jce.14687. Epub 2020 Jul 28.

Abstract

Background: Data on the optimal location of the electrocardiogram (ECG) leads for the diagnosis of drug-induced long QT syndrome (diLQTS) with torsades de pointes (TdP) are lacking.

Methods: We systematically reviewed the literature for the ECGs of patients with diLQTS and subsequent TdP. We assessed T wave morphology in each lead and measured the longest QT interval in the limb and chest leads in a standardized fashion.

Results: Of 84 patients, 61.9% were female and the mean age was 58.8 years. QTc was significantly longer in chest versus limb leads (mean (SD) 671 (102) vs. 655 (97) ms, p = .02). Using only limb leads for QT interpretation, 18 (21.4%) ECGs were noninterpretable: 10 (11.9%) due to too flat T waves, 7 (8.3%) due to frequent, early PVCs and 1 (1.2%) due to too low ECG recording quality. In the chest leads, ECGs were noninterpretable in nine (10.7%) patients: six (7.1%) due to frequent, early PVCs, one (1.2%) due to insufficient ECG quality, two (2.4%) due to missing chest leads but none due to too flat T waves. The most common T wave morphologies in the limb leads were flat (51.0%), broad (14.3%), and late peaking (12.6%) T waves. Corresponding chest lead morphologies were inverted (35.5%), flat (19.6%), and biphasic (15.2%) T waves.

Conclusions: Our results indicate that QT evaluation by limb leads only underestimates the incidence of diLQTS experiencing TdP and favors the screening using both limb and chest lead ECG.

Keywords: ECG; drug-induced long QT syndrome; screening; torsades de pointes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Electrocardiography
  • Female
  • Humans
  • Long QT Syndrome* / chemically induced
  • Long QT Syndrome* / diagnosis
  • Middle Aged
  • Pharmaceutical Preparations*
  • Torsades de Pointes* / chemically induced
  • Torsades de Pointes* / diagnosis
  • Ventricular Premature Complexes*

Substances

  • Pharmaceutical Preparations